Agape ATP Corp
ATPC1.359USD
+0.013+0.97%
Market hours （ET）Quotes delayed by 15 min
67.96MMarket Cap
LossP/E TTM
More Details of Agape ATP Corp Company
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. The Company offers four series of products: ATP Zeta Health Program, ENERGETIQUE, BEAUNIQUE and E.A.T.S. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake and unhealthy lifestyles. ENERGETIQUE series consists of the energy mask series, hyaluronic acid and mousse facial cleanser. Its BEAUNIQUE product series focuses on the research of its diet’s impact on modifying gene expressions in order to address genetic variations and deliver a personalized nutrigenomic solution for every individual.
Company Info
Ticker SymbolATPC
Company nameAgape ATP Corp
IPO dateSep 17, 2018
CEODr. Kok Choong How
Number of employees16
Security typeOrdinary Share
Fiscal year-endSep 17
Address1705-1708 Level 17, Tower 2, Faber Tower
CityKUALA LUMPUR
Stock exchangeNASDAQ Capital Market Consolidated
CountryMalaysia
Postal code58100
Phone60327325716
Websitehttps://www.agapeatpgroup.com/index.php/agape-atp-corporation/introduction
Ticker SymbolATPC
IPO dateSep 17, 2018
CEODr. Kok Choong How
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Kok Choong How
Dr. Kok Choong How
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
--
--
Dr. John Hing Vong
Dr. John Hing Vong
Deputy Chairman of the Board
Deputy Chairman of the Board
--
--
Mr. Kam Fan (Andrew) Lee
Mr. Kam Fan (Andrew) Lee
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tjong Budisantoso, Ph.D.
Mr. Tjong Budisantoso, Ph.D.
Executive Director
Executive Director
--
--
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Director
Director
--
--
Ms. Rose Marie Kadende Marie Kadende Kaiser
Ms. Rose Marie Kadende Marie Kadende Kaiser
Independent Director
Independent Director
--
--
Dr. Ni Luh Dharmakert Natih
Dr. Ni Luh Dharmakert Natih
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Kok Choong How
Dr. Kok Choong How
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Company Secretary
--
--
Dr. John Hing Vong
Dr. John Hing Vong
Deputy Chairman of the Board
Deputy Chairman of the Board
--
--
Mr. Kam Fan (Andrew) Lee
Mr. Kam Fan (Andrew) Lee
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tjong Budisantoso, Ph.D.
Mr. Tjong Budisantoso, Ph.D.
Executive Director
Executive Director
--
--
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Dr. Wilfrendo Fernando Cortizo, Ph.D.
Director
Director
--
--
Ms. Rose Marie Kadende Marie Kadende Kaiser
Ms. Rose Marie Kadende Marie Kadende Kaiser
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Others – Products for the provision of complementary health therapies
209.55K
72.50%
Health and wellness services
42.70K
14.77%
Ionized Cal-Mag
18.05K
6.24%
Skin care and healthcare products
8.68K
3.00%
LIVO 5
7.64K
2.64%
Other
2.42K
0.84%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Others – Products for the provision of complementary health therapies
209.55K
72.50%
Health and wellness services
42.70K
14.77%
Ionized Cal-Mag
18.05K
6.24%
Skin care and healthcare products
8.68K
3.00%
LIVO 5
7.64K
2.64%
Other
2.42K
0.84%
Shareholding Stats
Updated: Sat, May 10
Updated: Sat, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Lesser Panda Ltd
7.36%
Global Fartech Ltd
6.90%
Nexus Investments Group Ltd
6.07%
Oceanic Equity Partner Ltd
6.06%
Blue Horizon Capital Ltd
6.05%
Other
67.56%
Shareholders
Shareholders
Proportion
Lesser Panda Ltd
7.36%
Global Fartech Ltd
6.90%
Nexus Investments Group Ltd
6.07%
Oceanic Equity Partner Ltd
6.06%
Blue Horizon Capital Ltd
6.05%
Other
67.56%
Shareholder Types
Shareholders
Proportion
Corporation
51.32%
Individual Investor
1.97%
Other
46.71%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
20
26.65M
53.30%
+25.18M
2025Q1
20
26.65M
53.30%
+25.18M
2024Q4
10
1.46M
38.16%
+37.54K
2024Q3
10
1.42M
37.02%
+15.86K
2024Q2
9
1.40M
36.53%
-3.05K
2024Q1
8
1.40M
36.61%
+7.38K
2023Q4
3
1.39M
36.38%
+578.00
2023Q3
2
1.39M
36.92%
--
2023Q2
2
3.48M
39.27%
--
2023Q1
2
3.48M
39.27%
-386.93K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Lesser Panda Ltd
3.68M
7.36%
+3.68M
--
Mar 24, 2025
Global Fartech Ltd
3.45M
6.9%
+3.45M
--
Mar 24, 2025
Nexus Investments Group Ltd
3.04M
6.07%
+3.04M
--
Mar 24, 2025
Oceanic Equity Partner Ltd
3.03M
6.06%
+3.03M
--
Mar 24, 2025
Blue Horizon Capital Ltd
3.03M
6.05%
+3.03M
--
Mar 24, 2025
Global Ascend Ventures Ltd
3.02M
6.04%
+3.02M
--
Mar 24, 2025
Vanguard Development Holdings Ltd
3.02M
6.03%
+3.02M
--
Mar 24, 2025
Evergreen Strategic Capital Holding Ltd
3.01M
6.03%
+3.01M
--
Mar 24, 2025
Choong (How Kok)
980.45K
1.96%
+574.00
+0.06%
Jan 08, 2025
HKC Talent, Ltd
385.75K
0.77%
-26.50K
-6.43%
Jan 08, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Date
Type
Ratio
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
Aug 28, 2024
Merger
20<1
